Molecular Imaging / 2021 / Article / Tab 3 / Review Article
Comparison of Amino Acid PET to Advanced and Emerging MRI Techniques for Neurooncology Imaging: A Systematic Review of the Recent Studies Table 3 Summary of aaPET with MRS studies.
Study Year Study location No. of patients aaPET MRS Tumor type Main results Kudulaiti et al. [63 ] 2019 Shanghai, China 109 MET CNI Nonenhancing supratentorial glioma MET PET was more sensitive and specific than MRS, and when combined, sensitivity was higher and specificity stable. Kebir et al. [64 ] 2019 Essen, Germany 19 MET NAA, Cho, Cr Newly diagnosed glioma Both have limited potential in glioma subtyping. MET PET is better for differentiating IDH status and MRS for glioma subgrouping. Lundemann et al. [49 ] 2019 Copenhagen, Denmark 16 FET 3D MRSI Glioblastoma FET PET had the highest predictive value for recurrence. 3D MRSI was of insufficient quality for analysis. Verburg et al. [52 ] 2020 Amsterdam, Netherlands 20 FET CNI Newly diagnosed nonenhancing glioma FET PET combined with other modalities detects glioma infiltration better than standard MRI or FET PET. MRS data is insufficient due to limited sampling ability. Piccardo et al. [54 ] 2019 Genoa, Italy 22 FDOPA CNI, Cho/Cr, lactate Pediatric DMG Both could differentiate tumor grade and H3K27M mutation, but only FDOPA PET could do so independently of histology.
Cho: choline; Cr: creatine; CNI: choline-to-N-acetylaspartate index; NAA: N-acetylaspartate.